As the New Year commences, I suggest booking profits in 3 stocks viz. Bharat Electronics, Mahindra & Mahindra and Navkar Corp. The profits may be relatively small, but we see merit in staying as light as possible in January. We can take some to first gauge if the global flows will continue in Jan-21 and if valuations will hold. Here is a quick round up.
· Bharat Electronics at Rs.116 (CMP-121) – Book Profits
· M&M at Rs.700 (CMP-721) – Book Profits
· Navkar Corp at Rs.40 (CMP-43) – Book Profits
Being the last day of the week, you must avoid getting into fresh positions. I would suggest that you take a fresh view on the market next week after gauging the BREXIT reaction over the weekend. The big trigger will start from the second week of January and that is the quarter results which will start flowing in very soon.
The big story you must watch out for, and I will keep sharing my thoughts, is the pharma sector. With the massive rollout in favour of the vaccine, this sector needs to stretch itself well beyond its existing capacity to meet the global needs. I suggest you keep your radars open for opportunities in Gland Pharma, Aurobindo, Reddy Labs etc.
As the New Year commences, I suggest booking profits in 3 stocks viz. Bharat Electronics, Mahindra & Mahindra and Navkar Corp. The profits may be relatively small, but we see merit in staying as light as possible in January. We can take some to first gauge if the global flows will continue in Jan-21 and if valuations will hold. Here is a quick round up.
· Bharat Electronics at Rs.116 (CMP-121) – Book Profits
· M&M at Rs.700 (CMP-721) – Book Profits
· Navkar Corp at Rs.40 (CMP-43) – Book Profits
Being the last day of the week, you must avoid getting into fresh positions. I would suggest that you take a fresh view on the market next week after gauging the BREXIT reaction over the weekend. The big trigger will start from the second week of January and that is the quarter results which will start flowing in very soon.
The big story you must watch out for, and I will keep sharing my thoughts, is the pharma sector. With the massive rollout in favour of the vaccine, this sector needs to stretch itself well beyond its existing capacity to meet the global needs. I suggest you keep your radars open for opportunities in Gland Pharma, Aurobindo, Reddy Labs etc.